Prognostic Potential of Midregional Pro-Adrenomedullin Following Decompensation for Systolic Heart Failure: Comparison with Cardiac Natriuretic Peptides

Abstract

MR-proADM was found to correlate with the global disease burden in HF and proved a potent prognostic indicator, capturing the risk for both cardiac and non-cardiac death. Serial MR-proADM measurements further enhanced risk assessment, thus facilitating substantial reclassification.